Geistlich Pharma
Adam Kijowski is a Senior Regulatory Affairs Manager at Geistlich Pharma. Prior to this role, Adam worked as a Clinical Compliance Manager at Nobel Biocare and held various positions in clinical research and biology at prestigious institutions such as the University of Zurich. Adam has a strong background in molecular biology, specializing in membrane and protein trafficking, and has experience in managing interdisciplinary collaborations, data analysis, and scientific communication. Adam holds a Ph.D. in Molecular Life Sciences and a Doctor of Natural Sciences degree in Cell/Cellular and Molecular Biology.
This person is not in any offices
Geistlich Pharma
1 followers
Geistlich Pharma AG develops, produces and distributes medical devices and drugs (anti-infectives, vitamins) for regenerative medicine at the Wolhusen and Root sites in central Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its three business units Geistlich Biomaterials, Geistlich Surgery and Geistlich Medical have ten subsidiaries and global distribution. Some 500 employees work for the company around the world. The company is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas